Precision Functional Brain Mapping in Psilocybin

NCT04501653 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Psilocybin

Interventions

DRUG: Psilocybin
DRUG: Methylphenidate

Sponsor

Washington University School of Medicine